Crossmark

Clinical significance of lipoprotein(a) as a residual risk factor for atherosclerotic coronary plaque progression in statin-treated patients with coronary artery disease

Crossref DOI link: https://doi.org/10.1038/s41598-025-30845-1

Published Online: 2025-12-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fukase, Tatsuya

Dohi, Tomotaka

Takahashi, Norihito

Doi, Shinichiro

Okai, Iwao

Iwata, Hiroshi

Okazaki, Shinya

Miyauchi, Katsumi

Daida, Hiroyuki

Minamino, Tohru
License Information

Text and Data Mining valid from 2025-12-02

Version of Record valid from 2026-01-09
More Information

Article History

Received: 8 September 2025

Accepted: 27 November 2025

First Online: 2 December 2025

Declarations

:

: The authors declare no competing interests.

: The ethics committee of Juntendo Clinical Research approved this study (reference number E22-0409). This study was conducted in accordance with the Declaration of Helsinki.

: A written informed consent to participate was obtained from all patients.

Document is current

Any future updates will be listed below